354 related articles for article (PubMed ID: 1978737)
1. Muscarinic receptor activation attenuates D2 dopamine receptor mediated inhibition of acetylcholine release in rat striatum: indications for a common signal transduction pathway.
Drukarch B; Schepens E; Stoof JC
Neuroscience; 1990; 37(1):1-9. PubMed ID: 1978737
[TBL] [Abstract][Full Text] [Related]
2. Stimulation of D-2 dopamine receptors decreases the evoked in vitro release of [3H]acetylcholine from rat neostriatum: role of K+ and Ca2+.
Drukarch B; Schepens E; Schoffelmeer AN; Stoof JC
J Neurochem; 1989 Jun; 52(6):1680-5. PubMed ID: 2566646
[TBL] [Abstract][Full Text] [Related]
3. M-1 and M-2 muscarinic receptor-mediated inhibition of dopamine-sensitive adenylate cyclase in rat neostriatum: a permissive role for D-2 dopamine receptors.
Schoffelmeer AN; Hogenboom F; Mulder AH
J Pharmacol Exp Ther; 1988 May; 245(2):658-63. PubMed ID: 2452877
[TBL] [Abstract][Full Text] [Related]
4. Differential ontogeny of functional dopamine and muscarinic receptors mediating presynaptic inhibition of neurotransmitter release and postsynaptic regulation of adenylate cyclase activity in rat striatum.
De Vries TJ; Mulder AH; Schoffelmeer AN
Brain Res Dev Brain Res; 1992 Mar; 66(1):91-6. PubMed ID: 1350950
[TBL] [Abstract][Full Text] [Related]
5. Sustained activation does not desensitize the dopamine D2 receptor-mediated control of evoked in vitro release of radiolabeled acetylcholine from rat striatum.
Drukarch B; Schepens E; Stoof JC
Eur J Pharmacol; 1991 Apr; 196(2):209-12. PubMed ID: 1678719
[TBL] [Abstract][Full Text] [Related]
6. Frequency-dependent muscarinic receptor modulation of acetylcholine and dopamine release from rabbit striatum.
James MK; Cubeddu LX
J Pharmacol Exp Ther; 1984 Apr; 229(1):98-104. PubMed ID: 6707949
[TBL] [Abstract][Full Text] [Related]
7. Postsynaptic integration of cholinergic and dopaminergic signals on medium-sized GABAergic projection neurons in the neostriatum.
Harsing LG; Zigmond MJ
Brain Res Bull; 1998 Apr; 45(6):607-13. PubMed ID: 9566505
[TBL] [Abstract][Full Text] [Related]
8. Differential regulation of release of acetylcholine in the striatum in mice following continuous exposure to selective D1 and D2 dopaminergic agonists.
Wang HY; Zhou LW; Friedman E; Weiss B
Neuropharmacology; 1993 Jan; 32(1):85-91. PubMed ID: 8094235
[TBL] [Abstract][Full Text] [Related]
9. Depression of potassium-evoked striatal acetylcholine release by delta-receptor activation: inhibition by cholinoactive agents.
Ruzicka BB; Jhamandas K
Can J Physiol Pharmacol; 1988 Dec; 66(12):1487-92. PubMed ID: 2852536
[TBL] [Abstract][Full Text] [Related]
10. Restricted usefulness of tetraethylammonium and 4-aminopyridine for the characterization of receptor-operated K+-channels.
Drukarch B; Kits KS; Leysen JE; Schepens E; Stoof JC
Br J Pharmacol; 1989 Sep; 98(1):113-8. PubMed ID: 2553183
[TBL] [Abstract][Full Text] [Related]
11. Muscarinic receptors on dopamine terminals in the cat caudate nucleus: neuromodulation of [3H]dopamine release in vitro by endogenous acetylcholine.
Lehmann J; Langer SZ
Brain Res; 1982 Sep; 248(1):61-9. PubMed ID: 6289994
[TBL] [Abstract][Full Text] [Related]
12. D2-dopamine receptor-mediated inhibition of intracellular Ca2+ mobilization and release of acetylcholine from guinea-pig neostriatal slices.
Fujiwara H; Kato N; Shuntoh H; Tanaka C
Br J Pharmacol; 1987 Jun; 91(2):287-97. PubMed ID: 2886167
[TBL] [Abstract][Full Text] [Related]
13. Downregulation of muscarinic- and 5-HT1B-mediated modulation of [3H]acetylcholine release in hippocampal slices of rats with fimbria-fornix lesions and intrahippocampal grafts of septal origin.
Cassel JC; Jeltsch H; Neufang B; Lauth D; Szabo B; Jackisch R
Brain Res; 1995 Dec; 704(2):153-66. PubMed ID: 8788910
[TBL] [Abstract][Full Text] [Related]
14. Alterations in muscarinic control of striatal dopamine autoreceptors in senescence: a deficit at the ligand-muscarinic receptor interface?
Joseph JA; Dalton TK; Roth GS; Hunt WA
Brain Res; 1988 Jun; 454(1-2):149-55. PubMed ID: 3136856
[TBL] [Abstract][Full Text] [Related]
15. Decreased striatal release of acetylcholine following withdrawal from long-term treatment with haloperidol: modulation by cholinergic, dopamine-D1 and -D2 mechanisms.
Friedman E; Wang HY; Butkerait P
Neuropharmacology; 1990 Jun; 29(6):537-44. PubMed ID: 2200974
[TBL] [Abstract][Full Text] [Related]
16. In vitro effects of organophosphorus anticholinesterases on muscarinic receptor-mediated inhibition of acetylcholine release in rat striatum.
Liu J; Chakraborti T; Pope C
Toxicol Appl Pharmacol; 2002 Jan; 178(2):102-8. PubMed ID: 11814330
[TBL] [Abstract][Full Text] [Related]
17. Dopamine D-2 autoreceptors regulating the release of dopamine from cultured rat fetal dopaminergic neurons do not desensitize upon sustained activation: implications for the combined pharmaco- and grafting therapy in parkinsonian patients.
Van Muiswinkel FL; Drukarch B; Steinbusch HW; Stoof JC
Exp Neurol; 1994 Feb; 125(2):218-27. PubMed ID: 7906226
[TBL] [Abstract][Full Text] [Related]
18. Opposing effects of dopamine D2 receptor stimulation on the spontaneous and the electrically evoked release of [3H]GABA on rat prefrontal cortex slices.
Rétaux S; Besson MJ; Penit-Soria J
Neuroscience; 1991; 42(1):61-71. PubMed ID: 1677746
[TBL] [Abstract][Full Text] [Related]
19. Dopamine D-2 receptors inhibit D-1 stimulated cyclic AMP accumulation in striatum but not limbic forebrain.
Kelly E; Nahorski SR
Naunyn Schmiedebergs Arch Pharmacol; 1987 May; 335(5):508-12. PubMed ID: 2441268
[TBL] [Abstract][Full Text] [Related]
20. Nicotinic autoreceptors mediating enhancement of acetylcholine release become operative in conditions of "impaired" cholinergic presynaptic function.
Marchi M; Raiteri M
J Neurochem; 1996 Nov; 67(5):1974-81. PubMed ID: 8863503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
